Clinical Trials in Spain / NCT07837947
Starting soon Not applicable

Air Polishing for Pain and Compliance in Supportive Periodontal Therapy

NCT07837947 · tracked via the Priya Life Science Spain tracker
Sponsor
Octavi Camps-Font
Phase
Not applicable
Started
2026-10
Last updated
2026-09-24

Condition(s) studied

Periodontitis

Investigational drug(s) / intervention(s)

Trehalose Air-PolishingUltrasonic Instrumentation

Trehalose Air-Polishing: Subgingival biofilm removal during supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder.

Ultrasonic Instrumentation: Conventional subgingival debridement during supportive periodontal therapy using ultrasonic instrumentation.

Study summary

Supportive periodontal therapy (SPT) is essential for maintaining periodontal stability and preventing disease recurrence in patients who have been successfully treated for periodontitis. However, long-term effectiveness depends on regular attendance at maintenance visits, and negative experiences associated with periodontal instrumentation, such as pain or discomfort, may affect patient acceptance and adherence to the maintenance program.

The aim of this randomized clinical trial is to evaluate whether supportive periodontal therapy performed using an air-polishing device with low-abrasive trehalose powder reduces patient-perceived pain and improves the clinical experience compared with conventional biofilm removal using ultrasonic instrumentation. The study will also assess whether the use of air polishing is associated with better adherence to the periodontal maintenance program while maintaining comparable periodontal clinical outcomes.

Forty periodontally stabilized adult patients enrolled in the supportive periodontal therapy program of the Master's Degree in Periodontology and Peri-implantology at the University of Barcelona will be randomly allocated in a 1:1 ratio to one of two parallel treatment groups. The control group will receive conventional supportive periodontal therapy using ultrasonic instrumentation, while the experimental group will receive supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder. Participants will be followed for 24 months.

The primary outcome will be patient-perceived pain associated with supportive periodontal therapy, assessed using a visual analogue scale (VAS). Secondary outcomes will include treatment duration, adherence to scheduled maintenance visits, patient experience and acceptance of treatment, and periodontal clinical parameters. Periodontal status will be monitored throughout follow-up by assessing probing pocket depth, clinical attachment level, bleeding on probing, and plaque index.

This study aims to determine whether air polishing with trehalose powder can provide a more comfortable and patient-centered approach to supportive periodontal therapy without compromising periodontal clinical outcomes, and whether an improved treatment experience may contribute to better long-term adherence to periodontal maintenance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Men or women aged 18 years or older who voluntarily agree to sign the informed consent form before any study-related procedure is performed. * ASA physical status I or II. * Initial diagnosis of Stage I-III periodontitis according to the 2017 World Workshop, periodontally treated and stabilized, and enrolled in a supportive periodontal therapy (SPT) program. * Non-smokers or light smokers (\<10 cigarettes/day). * Commitment to attend all follow-up visits over the 24-month study period. Exclusion Criteria: * Patients requiring local anesthesia or anxiolytic premedication to undergo supportive periodontal therapy (SPT). * Patients with pacemakers, implantable cardioverter-defibrillators, or neurostimulators. * Pregnant women. * Patients with infectious respiratory diseases. * Patients with systemic diseases or neurological disorders that may alter pain perception. * Patients receiving medications that may influence pain perception (e.g., opioids or gabapentin).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Odontològic Universitat de Barcelona L'Hospitalet de Llobregat Barcelona

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07837947 on ClinicalTrials.gov ↗ ← All trials in Spain